HTfTnTJ^CTS

1. Case Western University, [home page on the internet] Available from pic. cwru. edu/tutorial/enhanced/files/polymers/Intro. htm.

2. Vastleios Koustos, Introduction to Polymers, The University of Edinberg, Division of Engineering, Materials Science and Engineering, May 2002.

3. University of California at Barkeley [home page on the internet]. Introduction to Polymers Available from: http://www.csua.berkeley.edu/~ranga/school/me223/-intro4.html

4. Camille and Henry Dreyfus Foundation, [home page on the internet] Available from: http://chemistry2.csudh.edu/rpendarvis/PoIymer.html

5. University of California at Barkeley, Introduction to Polymers, [home page on the internet] Available from: http://www.csua.berkeley.edu/~ranga/school/-me223/intro2.html

6. Sane RT, Jagdish K Ghadge. Thermal Analysis - Theory and Applications, Quest PubUcations; 1997.

7. University of California at Barkely. [home page on the internet] Available from: http://www.csua.berkeley.edu/~ranga/school/me223/-intro6.html

8. Case Western University, [home page on the internet] Available from: http://plc.cwru.edu/tutorial/enhanced/files/polymers/apps/apps.htm

9. University of California at Barkely, Introduction to Polymers at http://www.csua.berkeley.edu/~ranga/school/me223/intro5.html

10. Imperial College, [home page on the internet] London: Available from: www. ch. ic. ac.uk/local/organic/tutorial/steinke/StructurePorpertyRelation ships2003.pdf

11. Blaine J. Lancet. 1946; 2:525.

12. Ingraham FD, Alexander E, Matson DD. New Engl J Med. 1947; 236:362.

13. Alfred Martin, James Swarbrick, Arthur Cammarata, editors. Physical Pharmacy. 3"* ed. Philadelphia: Lea and Febiger; 1983.

14. Williams DF. Definitions of Biomaterials in Progress in Biomaterials (Vol. 4); Elsevier Press: 1987).

15. Dimitriu S Polymeric Biomaterials. Marcel Dekker; 1994.

16. Piskin E, Hoffman AS. Polymeric Biomaterials. The Netherlands: Nijhoff Publications; 1986.

165

17. Atala A, Mooney DJ. Synthetic Biodegradable Polymer Scaffolds. Boston: Birkhauser; 1997.

18. Tarcha PJ. Polymers for Controlled Drug Delivery. Florida: CRC Press; 1991.

19. Kim SC, Sperling LH, editors. Interpenetrating Polymer Networks Around the World: Science and Engineering. John Wiley & Sons; 1997.

20. Katono H, Sanui K, Ogata N, Okano T, Sakurai Y. Drug Release OFF Behavior and Deswelling Kinetics of Thermo-Responsive IPNs Composed of Poly(acrylamide-co-butyl methacrylate) and Poly(acrylic acid). Polym J. 1991; 23:1179-1189.

21.Tohru Natsume, Osamu Ike, Toshiyuki Okada, Nobuyuki Takimoto, Yasuhiko Shimizu, Yoshito Ikada. Porous collagen sponge for esophageal replacement. J Biomed Mater Res. 1993; 27:867-875.

22. Cremers HFM. et al. Albumin-heparin microspheres as carriers for cytostatic agents. J Control Release. 1990; 11:167-179.

23. Long DD, Luyen DV. J Macromol Sci-Pure Appl Chem. A33; 1996:1875-1884.

24. Forster M, Mansfeld J, Dautzenberg H, Schellenberger A. Immobilization in polyelectrolyte complex capsules: Encapsulation of a gluconate-oxidizing Serratia marcescens strain Enzyme Microb. Enzyme Microb Technol. 1996; 19:572-577.

25. Iwata H. et al. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas J Biomed Mater Res. 1994; 28:1003-1011.

26. Prokop A, Hunkeler D, DiMari S. Haralson MA, Wang TG. Soluble Polymers for Immunoisolation I: Complex Coacervation and Cytotoxicity. Adv Polym Sci. 1998; 136:1-51.

27. Nijenhuis KT. Carrageenans. Adv Polym Sci. 1997; 130:203-218.

28. Chakravarthy D, Smith DJ. Preparation of a Dextran-Based Degradable Absorbent Suitable for Wound Healing Applications. J Bioact Compat Polym. 1995; 10:313-326.

29. Yao KD, Peng T, Yin YJ. Xu MX Goosen MFA. J Macromol Sci-Rev. Macromol Chem Phys. 1995; C35:155-180

30. Heller J. Poly(ortho esters). Adv Polym Sci. 1993; 107:41-92.

31. Vezin WR, Florence AT. In vitro heterogeneous degradation of poly(«-alkyl a-cyanoacrylates). J Biomed Mater Res. 1980; 14:93-106.

166

32. Allcock HR. In: Allen G. editor. Comprehensive Polymer Science. Pergamon Press; 1982.

33. Allcock HR. In: Chasin M, Langer R, editors. Biodegradable Polymers as Drug Delivery Systems.Marcel Dekker;1990. p 163-193.

34. Miguez MJ, Rodrigues BC, Sanchez MNM, Laranjeira MCM. J Microencap. 1997; 14:639-646.

35. Zalipsky S. Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates. Bioconjugate Chem. 1995; 6:150-165.

36. Bhatia S. et al. J Neurosci. 1995; 83:897-902.

37. Nijenhuis KT. poly(vinyl methacrylate). Adv. Polym. Sci. 1997; 130:67-81.

38. Rawlins EA, Editor. Bentley's Text book of Pharmaceutics. ELBS; 1977. p. 269-310.

39. James AS, Shashi P, James L. Tablet Coating. In: The theory and practice of Industrial Pharmacy Leon Lachman, Herbert AL, Josep LK, editors. 3''* Ed., Philadelphia: Lea & Febiger; 1986. p 346.

40. Schmitt EE. PoUstina, R. A. In U.S. Patent, 1967.

41. Wong WH, Mooney DJ. In: Synthetic Biodegradable Polymer Scaffolds. Atala, Mooney. editors. Boston, MA: Birkhauser; 1997.

42. Lanza RP, Langer R, Chick WL. Principles of Tissue Engineering; Austin, TX: Academic Press; 1997.

43. HoUinger JO. Boca Raton, FL: CRC Press; 1995.

44. Shalaby SW. In: Biomedical Polymers: Designed-to-Degrade Systems. Shalaby SW. editor. Cincinnati, OH: Hanser-Gardner; 1994.

45. Marco van de W, Marinus JVS, Jeffrey LC, Jorge H, Wim EH, Daan JAC. Semisolid, self-catalyzed poly(ortho ester)s as controUed-release systems: Protein release and protein stability issues, J Pharm Sci. 2002; 91(4): 1065-1074.

46. Zhong Zhao, Jun Wang, Hai-Quan Mao, Kam WL. Polyphosphoesters in drug and gene delivery. Adv Drug Del Rev. 2003; 55:483-499.

47. Hellera J, Barra J, Nga SY, Shena HR, Schwach-Abdellaouib K, Emmahlb EA, et al. Poly(ortho esters)-their development and some recent appUcations, Eu J Pharm Biopharm. 2000; 50:121-128.

167

48. Suzanne E, Sergio C, Khadija SA, Michael M, Francine BC, Robert G. Therapeutic applications of viscous and injectable poly(ortho esters), Adv Drug Del Rev. 2001; 53:45-73.

49. Lea AD, Matthias W, Thomas K. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles. J Cont Rel. 2005; 101:137-149.

50. Kimura Y. Biomedical Applications of Polymeric Materials. Boca Raton, FL.CRC Press; 1993.

51. Agrawal CM. Athanasiou KA. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J. Biomed. Mater. Res. 1997; 38:105.

52. Rajeev AJ. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycoUde) (PLGA) devices. Biomaterials. 2000; 21:2475-2490.

53. Wolfgang Friess., Monika Schlapp. Release mechanisms from gentamicin loaded poly(lactic-co-glycoUc acid) (PLGA) microparticles. J Pharm Sci. 2002; 91(3):845 - 855.

54. Rubiana MM, Raul CE. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005; 290:137-144

55. Chen D, Bei J, Wang S. Polycaprolactone microparticles and their biodegradation. Polym Deg Stab. 2000; 67:455-459.

56. Cheung YW, Stein RS, Lin JS, Wignall GD. Small-angle scattering investigations of poly(epsilon-caprolactone) polycarbonate blends.2. Small-angle X-ray and light-scattering study of semicrystalline semicrystalline and semicrystalline amorphous blend morphologies. Macromolecules. 1994; 27:2520-2528.

57. Koenig M, Huang S. Biodegradable blends and composites of polycaprolactone and starch derivatives. Polymer. 1995;36: 1877-1882.

58. Oiabarrieta I, Forsstrom D, Gedde U, Hedenqvist M. Transport properties of chitosan and whey blended with poly(epsiloncaprolactone) assessed by standard permeability measurements and microcalorimetry. Polymer. 2001; 42:4401-4408.

59. Rosen HB, Chang J, Wnek GE, Linhardt RJ, Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials. 1983; 4:131-133.

60. Uhrich ke, Gupta A, Thomas TT, Laurencin CT, Langer R. Synthesis and characterization of degradable poly-anhydride-co-imides). Macromolecules. 1995; 28:2184-2193.

168

61. Uhrich KE, Thomas TT, Laurencin CT, Langer R. In vitro degradation characteristics of poly(anhydride-co-imides) containing trimellityimidoglycine. J AppI Polym Sci. 1997; 63:1401-1411.

62. Young JS, Gonzales KD, Anseth KS. Photopolymers in orthopedics: characterization of novel crosslinked polyanhydrides. Biomaterials. 2000; 110:1181-1188

63. Muggli DS, Burkoth AK, Anseth KS. Crosslinked poly-anhydrides for use in orthopedic applications: degradation behavior and mechanics. J Biomed Mater Res. 1999; 46:271-278.

64. Jiang HL, Zhu KJ. Preparation, characterization and degradation characteristics of polyanhydrides containing poly(ethylene glycol), Polym. Int. 48 (1999) 47-52.

65. Domb A, Maniar M. Absorbable biopolymers derived from dimer fatty acids. J Poly Sci. 1993; 31(5): 1275-1285.

66. Domb A, Nudelman R. In vivo and in vitro elimination of aliphatic polyanhydrides. Biomaterials. 1995; 16:319-323.

67. Domb AJ, Nudelman R. Biodegradable polymers derived from natural fatty acids. J Poly Sci. Part A: Polym. Chem. 1995; 33:717-715.

68. Andrade JD, Hlady V, Jeon SI. Poly(ethyleneoxide) and protein rsistance, principles, problems and prossibilities. Adv. Chem. 1996; 248:51.

69. Nucci ML, Shorr R, Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Del Rev. 1991; 6:133-151

70. Katre N. The conjugation of proteins with polyethylene glycol and other polymers: Altering properties of proteins to enhance their therapeutic potential. Adv Drug Del Rev. 1993; 10:91-114.

71. Gref R, Minamitake Y, Perachhia MT, Trubetskoy, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994; 263: 1600-1603.

72. Sahli H, Bretaudiere J, Fischer AM, Sternberg C, Spenlehauer G, Verrecchia T, Labarre D. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials. 1997; 18:281.

73. Cannizzaro SM, Padera RF, Langer R, Rogers RA, Black FE, Davies MC, Tendler SJB, Shakeshefif KM. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol Bioeng. 1998; 58(5): 529-535.

169

74. Nathan A, Kohn J. In: Shalaby SW. editor. Biomedical Polymers: Designed-to-Degrade Systems. Cincinnati:OH: Hanser-Gardner; 1994.

75. Anderson J, Gibbons D, Martin R, Hiltner A, Woods R. The potential for poly-a-amino acids as biomaterials. J Biomed Mater Res. 1974; 5:197.

76. Langer R, Peppas N. Rev Macromol Chem Phys. 1983; C23:61

77. Marck K, Wildevuur C, Sederel W, Bantjes A, Feijen J. Biodegradability and tissue reaction of random copolymers of L-leucine, L-aspartic acid, and L-aspartic acid esters. J Biomed Mater Res. 1977; 11:405.

78. Martin E, May P, McMahon W. Amino acid polymers for biomedical appUcations. I. Permeability properties of L-Ieucine Dl-methionine copolymers. J Biomed Mater Res. 1971; 5:53.

79. Conforti A, Bertani S, Lussignoli S, Grigolini L, Terzi M, Lora S, Caliceti P, Marsilio F, Veronese FM. Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems. J Pharm Pharmacol. 1996; 48:468.

80. AUcock HR, Pucher SR, Scopelianos AG. Poly[(amino acid ester)phosphazenes] as substrates for the controlled release of small molecules. Biomaterials. 1994; 15:563.

81. Ruiz EM, Ramirez CA, Aponte MA. Barbosa-Canovas GV. Degradation of poly[bis(glycine ethyl ester)phosphazene] in aqueous media. Biomaterials. 1993; 14:491.

82. Crommen JH, Schacht E. Biodegradable polymers:II. Degradation characteristics of hydrolysis-sensitive poly[(organo)phosphazenes]. Biomaterials. 1992; 13: 601.

83. Andrianov AK, Payner LG, Visscher KB. Allcock HR, Langer R. Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres. J AppI Polym Sci. 1994; 112:832.

84. Cohen S, Bano MC, Visscher KB, Chow M, Allcock H, Langer R. Ionically crosslinkable Polyphosphazene: A novel Polymer for microencapsulation. J Am Chem Soc. 1990; 112:7832.

85. Allcock HR, Ambrosio AMA. Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels. Biomaterials. 1996; 17:2295.

86. USP XXIV and National Formulary. U.S.Pharmacopeial Convention. 2000; 246-2428.

87. H P Brown, US Patent No. 2798053 (1957).

170

88. B F Goodrich Bulletin: "Sustained Release Patents using Carbopol Resin"B F Goodrich Company, Cleveeland, OH, 1987.

89. Carnali JO, Naser MS. The Use of Dilute Solution Viscosity to Characterize the NetworkProperties of Carbopol Microgels. Col Poly Sci. 1992; 270(2): 183-193.

90. Garcia-Gonzalez N, Kellaway IW, Blanco Fuente H, Anguiano Igea S, Delgado Charro, Otero B, Espinar FJ, Mendez J. Influence of Glycerol Concentration and Carbopol Molecular Weight on Swelling and Drug Release Characteristics of Metoclopramide Hydrogels. Int J Pharm. 1994; 104:107-113.

91. B F Goodrich Company Technical Literature: Carbopol Resin Handbook, 1991.

92. Alexander P, Organic Rheological Additives, Mfg. Chem. 1986; 57(10):81-84.

93. Noveon Company Technical Literature, 2005.

94. Martindale - The Complete Drug Reference, 33"^ Edition 2002 (1499).

95. Lochhead RY, Davidson JA, Thomas GM. Polym Aq Media. 1989; 13-147

96. Advances in Polymer Science, Vol. 109 & 110, Responsive Gels: I & II, Springer-Verlag.

97. Peppas NA, Characterization of Cross-linked Structure of Hydrogels. Hydrogels in Mediciines and Pharmacy Vol. 1. Fundamentals, CRC Press, Boca Raton, FL, 1986; 27:56.

98. Brannon-Peppas L, Preparation and Characterization of Cross-linked HydrophiUc Networks. Sud Polym Sci. 1990; 8:45-66.

99. Hooper HH et al. Swelling Equilibrium for Positively Ionized Poly(acrylamide) Hydrogels. Macromolecules. 1990; 23(4): 1096-1104.

100. Taylor, Bagley. Tailoring Closely Packed Gel-Particles Systems for Use as Thickening Agents. J AppI Polym.Sci. 1977; 21:113-122.

101. Taylor, Bagley. Rheology of Dispersions of Swollen Gel Particles, J Poiym Sci.-Polymer Physics Ed. 1975; 13:1133-1144.

102. Ishikawa S et al. Evaluation of the Rheological Properties of Various Kinds of Carboxyvinyl polymer Gels. Chem Pharm Bull. 1988; 36(6):2118-2127.

171

103. Choulis NH, Papadopoulos H, Choulis M. Long Acting Methadone. Pharmazie. 1976; 31: H7.

104. Durrani, Manzer J, Whitaker, Roy, Benner, Samuel C. A Comparative Study of Controlled Release Agents-I: Effects of Compression Force and Polymer Concentration. Amer Assoc Pharm Sci. 1992. Nov.

105. Perez-Marcos B, Gutierrez C, Gomez-Amoza J, Martinez-Pacheco R, Souto C, Concheiro A. Usefulness of Certain Varieties of Carbomer in the Formulation of Hydrophilic Furosemide Matrices. Int J Pharm. 1991; 67(2):113-121

106. Perez-Marcos B, Iglesias R, Gomez-Amoxa JL. Mechanical and Drug Release Properties of Atenolol-Carbomer Hydrophilic Matrix Tablets. J Cont Release. 1991; 17(3):267-276.

107. Guo JH. Investigating the Bioadhesive Properties of Polymer Patches for Buccal Drug Delivery (Carbopol 934P). J Cont Rel. 1994; 28(1):272-273.

108. Guo JH Bioadhesive Polymer Buccal Patches for Buprenorphine Controlled Delivery Formulation: In Vitro Adhesion and Release Properties. Drug Dev Ind Pharm. 1994; 20(18):2809-2821.

109. Davies NM, Farr SJ, Hadgrafl J, Kellaway IW. Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery-I. Viscous Solutions. Pharm Res. 1991; 8(8): 1039-1043

110. Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery-II. Polymer-Coated Vesicles. Pharm Res 1992; 9(9): 1137-44.

111. Akiyama Y, Nagahara N, Hirai S, Toguchi H. In Vitro and In Vivo Evaluation of Mucoadhesive Microspheres Prepared for the Gastrointestinal Tract Using Poly glycerol Esters of Fatty Acids and a Poly(Acrylic Acid) Derivative. Pharm Res. 1995; 12(3):397-405.

112. Micheal lU, Exaud S, Guy VDM, Norbert V, Renaat K. Nasal Mucoadhesive Delivery Systems Of the Anti-parkinsonian Drug Apomorphine. Influence of Drug-Loading on In vitro and In vivo Release in Rabbits Int J Pharm. 1999; 181:125-138.

113. Claudia V, Constantia EK, Irene H, Andreas B. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Cont Rel. 2001; 77:323-332

114. ElHady SSA, Mortada ND, Awad GAS, Zaki NM, Taha RA. Development of insitu gelling and mucoadhesive Mebeverine Hydrochloride solution for rectal administration. Saud Pharm J. 2003; 11(4):59-169

172

115. Al-Khamis KI, Davis SS, Hadcraft J. Microviscosity and Dmg Release from Topical Gel Formulations. Parma Res. 1986; 3(4):214-217.

116. Briede RH. Application of Carbomer water Gel 1%. Pharm Week. 1983; 118(9):170-174

117. Berney BM, Deasy PB. Evaluation of Carbopol 934P as a suspending agent for Sulfademidine suspensions. Int J Pharm. 1979; 3(2-3):73-80.

118. Baun DC, Walker, George Carmichael. Prolonged Release of Caramiphen Hydrochloride and Atropine Sulfate from Compressed Tablets Containing Carbopol 934. Pharm Acta Helv. 1971; 46(2):94-113

119. Choulis NH, Papadopoulos H, Choulis M. Long Acting Methadone. Pharmazie. 1976; 31:H.7.

120. Durrani Manzer J, Whitaker Roy, Benner, Samuel C. A Comparative Study of Controlled Release Agents-I Effects of Compression Force and Polymer Concentration. Amer Assoc Pharm Sci. 1992; Nov.

121. Durrani Manzer J, Whitaker R, Andrews, Audrey, Greenberg, Edward, Wiggins M. Studies on Drug Release Kinetics from Carbopol 974P Tablets-Sixth AAPS Meeting. Washington DC. 1991: October.

122. Durrani MJ, Todd R, Andrews A, Whitaker RW, Greenberg E, Benner SC. Polymer Concentration Effects on Carbopol 934 Tablets for Controlled Release. Proceed. Int Symp Cont Rel Bioact Mater Cont Rel Soc Inc. 1992; July.

123. Durrani MJ, Whitaker R, Andrews, Audrey, Todd, Richard E, Benner, Samuel C. A comparative study of controlled release agents. Amer Assoc Pharm Sci. 1992; Nov.

124. Durrani MJ, Manji PA, Whitaker RF, Huvard GS. Controlled release studies on Carbopol971P polymer. Proc Int Symp Controlled Release Bioact Mater-21st. 1994; 738-739.

125. Borodkin P, Woodward L, Li P, Diesner C, Harmandez L, Vadnere M, Lu MF. A Polymer Carrier System for Taste Masking of Macrolide Antibiotics Pharm Res. 1991; 8(6):706-712.

126. Delgado A, Gallardo V, Parera A, Gonzalez CF. A study of the Electrokinetic and stability properties of Nitrofiirontoin suspensions Part-II. Flocculation and redispersion properties as compared with theoretical interaction energy curves. J Pharm Sci. 1990; 9(8), 709-715.

173

127. Anlar S, Capan Y, Hincal AA. Physico-Chemical and Bioadhesive Properties of Polyacrylic Acid Polymers. Pharmazie. 1993; 48(4):285-287.

128. Chang HS, Park H, Kelly P, Robinson JR. Bioadhesive Polymers as Platforms for Oral Controlled Release Drug Delivery-II: Synthesis and Evaluation of Some Swelling, Water insoluble Bioadhesive Polymers. J Pharmacol Sci. 1985; 74:229.

129. Smart JD. Some Formulation Factors Influencing the Rate of Drug Release from Bioadhesive Matrices. Drug Dev Ind Pharm. 1992; 18(2):223-232.

130. Smart JD, An in vitro assessment of some mucosa adhesive dosage forms. Int J Pharm. 1991; 73(l):69-74.

131.Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery II. Polymer coated vesicles. Pharm Res. 1992; 9(9):1137-1144.

132. de Leeuw BJ, Lueben HL, Perard D, Verhoef AC, de Boer AG, Junginger HE. The effect of mucoadhesive poly(acrylates) polycarbophil and carbomer on zinc and calcium dependent proteases. Proceed Intern Symp Cont Rel Bioact Mater. 1995; 22:2123.

133. Lehr CM, Bouwstra JA, Tukker J J, Verhoef AC, de Boer AG, Junginger HE, Breimer DD. Oral bioadhesive drug delivery systems - effects on g.i. Transit and peptide absorption. Pharm Res. 1990; (Sep Suppl PDD 7226):7(9).

134. Leung SH, Irons BK, Robinson JR. Polyanionic hydrogel as a gastric retentive system. J Biomat Sci Polymer Ed. 1993; 4(5):483-492.

135. Longer MA, Chang HS, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery- iii: oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci. 1985; 74(4):406-411.

136. Lueben HL, Lehr CM, Rentel CO, Noach ABJ, de Boer AG, Verhoef JC, Merckle HP, Junginger HE. Effect of Poly(Acrylates) on the Enzymatic Degradation of Peptide Drugs by Intestinal Brush Border Membrane Vesicles J Cont Rel. 1993; 29(l):329-338.

137. Lueben HL, Bohner VP, Langguth P, Verhoef AG, de Boer AG, Verhoef JC, Junginger HE . Bioadhesive Polymers for the Peroral Delivery of Peptide Drugs (Polycarbophil, Carbopol® 934P NF, Chitosan). Proceed. Intern Symp Cont Rel Bioact Mater. 1995; 22:2124.

138. Anlar S, Capan Y, Hincal AA. Physico-Chemical and Bioadhesive Properties of Polyacrylic Acid Polymers. Pharmazie. 1993; 48(4):285-287.

174

139. Gumma A. Measurability of the bioavailability of an active principle applied topically. Pharm Acta Helv. 1971; 46(12):7306.

140. Ruiz MA, Gallardo V, Delgado A, Vera P. Study of in-vitro release of corticoids in topicals formulations. Farmaco. 1994; 49(2): 147-52.

Hl.Sanghavi NM, Puri RD, Kamath PR. Study on topical piroxicam formulations. Indian Drugs. 1989; 26(4): 165-168.

142. Strauss JS, Goldman PH, Nacht S, Gans EH. A reexamination of the potential comedogenicity of sulphur. Arch Dermitol. 1978; (September) 114.

143. Thoma VK, Klimek R. Investigations on photoinstability of nifedipine-part 3. Pharm Ind. 1991; 53(4).

144. Yusef A. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions (patent appUcation). 1993.

145. M Pader. Rheological Properties of Cosmetics and Toiletries, New York: Marcel Dekker; 1993.

146. Gaffar A, Afflitto J, Nuran N. Chemtech. 1993; 23(7):38-42.

147. Prencipe M, Masters JG, Thomas KP, Norfleet J. Chemtech. 1993; 25(12):38-42.

148. M. Pader. Gel Toothpastes: Genesis. Cosmetics & Toiletries. 1983; 98:71-76.

149. Muzzarelli RAA, Baldassare V, Conti F, Gazzanelli G, Vasi V, Ferrara P, Biagini G. The biological activity of chitosan: uhrastructural study. Biomaterials. 1988; 8:247-252

150. Miyazaki S, Ishii K, Nadai T. The use of chitin and chitosan as drug carriers. Chem Pharm Bull. 1981; 29: 3067-3069.

151. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992; 78:43-48

152. Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gumy R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention Int J Pharm. 1999; 180:185-193.

153. Cartier N, Domard A, Chanzy H. Single crystals of chitosan. Int J Biol Macromol 1990; 12:289-94.

175

154. Domard A, Cartier N. Glucosamine oligomers: solid state crystallization and sustained dissolution. Int J Biol Macromol. 1992; 14: 100-106.

155. Khan TA, Peh KK, Ching HS. Reporting degree of deacetylation values of chitosan: the influence of analytical methods. J Pharm Pharm. Sci. 2002; 5(B):205.

156. Kas HS. Chitosan: properties, preparations and application to microparticulate systems. J Microencap. 1997; 14:689.

157. Sandford PA. Chitosan: commercial uses and potential applications. In: Skjak-Braek G, Anthonsen T, Sandford P, eds. Chitin and Chitosan -Sources, Chemistry, Biochemistry, Physical Properties & Applications. London, UK: Elsevier; 1989. p 51-69.

158. Sawayanagi Y, Nambu N. and Nagai T. Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch. Chem Pharm Bull. 1982; 30:2935-2940

159. Ritthidej GC, Chomto P, Pummongura S, Menasveta P. Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev Ind Pharm. 1994; 20(13):2109-2134.

160. Upadrashtra SM, Katikanen PR, Nuessle NO. Chitosan as a tablet binder. Drug Dev Ind Pharm. 1992; 18(15): 1701-1708

161. Miyazaki S, Ishii K, Nadai T. Use of chitin and chitosan as drug carriers. Chem Pharm Bull. 1981; 29:3067-3069.

162. Nagai T, Sawayanagi Y, Nambu N. In: Zikakis J, editor. Chitin, Chitosan and Related Enzymes. Acadenuc Press Inc; 1984. p 21.

163. Sawayanagi Y, Nambu N, Nagai T. Use of chitosan for sustained-release preparations of water-soluble drugs. Chem Pharm Bull. 1982; 30(11):4213-4215.

164. Ohaya T, Takin HK, Obayashi, Touchs. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J Microencap. 1993; 10(1): 1-9.

165. US Patent 4, 659, 1984 Chemical Abstracts 108 (20), 1998.

166. Miyazaki S, Ishini K, Nadai T. Use of chitin and chitosan as drug carriers Chem Pharm Bull. 1981; 29:3067-3069.

167. Thacharodi D, Pandurangarao K. Release of nifedipine throught crosslinked chitosan membranes. Int J Pharm. 1993; 96:33-39.

176

168. Thacharodi D, Pandurangarao K. J Chem Tech Biotechnol. 1993; 58:177.

169. Thacharodi D, Pandurangarao K. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: Development and in vitro evaluations. Biomaterials. 1996; 17:1307-1311.

170. Kanke, Motok, Kayyano, Truzxki, Symi, Kuranato, Hiromi. Chem Pharm Bull. 1989; 37(2):523.

171. Gershon Colombo, Matilds Levi, Joel, Van Gelder M. Controlled release of bisphosphonate from a biodegradable implant: Evaluation of release kinetics and anticalcification effect. J app Biomat. 1992; 3:23-28.

172. Hou WM, Miyazaki S, Takada M, Kornai T. Sustained release of indomethacin from chitosan granules. Chem Pharm Bull. 1985; 33:3986-3992.

173. Thanoo BC, Sunny MC, Jayakrishnan A. Cross hnked chitosan mocrospheres: preparation and evaluation as a matrix ofor the controlled release of pharmaceuticals. J Pharm Pharmacol. 1992; 44:283-286.

174. Denkbas FB, Seyyad M, Piskin F. 5-Fluorouracil loaded chitosan microspheres for chemoembolization. J Mieroencap. 1999; 16(1):741-749.

175. Nishioka Y, Kyotani S, Okamura M, Miyazaki M, Okazaki K, Ohnishi S,Yamamoto Y. Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chem Pharm Bull. 1990; 38:2871-2873.

176. Jameela SR, Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials. 1995; 16:769-775.

177. He P, Davis SS, Ilium C. Sustained release chitosan microspheres prepared by novel spray drying methods. J Mieroencap. 1999; 16:343-355.

178. He P, Davis SS, Ilium. L. In vitro evaluation of the mucoadhesioive properties of chiosan microsheres. Int J Pharm. 1998; 166:75-88.

179. Takayama K, Hirata M, Machida Y, Masada T, Sonnan T, Nagai T. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate Chem Pharm Bull. 1990; 38:1993-1997.

177

180. Schipper NGM, Vamm KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. Part 1. Influence of molecular weight and deree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res. 1996; 13:1686-1692

181. lonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003; 55: 1451-1463.

182. Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm World Sci. 2004; 26: 137-142.

183. Cerchiara T, Luppi B, Bigucci F, Zecchi V. Chitosan saUs as nasal sustained delivery systems for peptidic drugs. J Pharm Pharmacol. 2003; 55:1623-1627

184. Soane RJ, Hinchcliffe M, Davis SS, Ilium L. Clearance characteristics of chitosan- based formulations in the sheep nasal cavity. Int J Pharm. 2001; 17: 183-191

185. Sankar C, Rani M, Srivastava AK, Mishra B. Chitosan-based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie. 2001; 56: 223-226.

186. Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Ilium L. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res. 2002; 19: 998-1008.

187. Ilium L, Jabbal-Gill I, Hinchchffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001; 51(l-3):81-96

188. Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Del Rev. 1993; 11: 179-191.

189. Anders R, Merkle HP. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm. 1989; 49: 231-240.

190. Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull. 1994; 17: 745-747

191. Giunchedi P, JuUano C, Gavini E, Cossu M, and Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Euro J Pharm Biopharm. 2002; 53: 233-239.

178

192. Remunan-Lopez C, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Cont Rel. 1998; 55: 143-152.

193. Park CR, Munday DL. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine. Drug Dev Ind Pharm. 2004; 30: 609-617.

194. Genco RJ. Antibiotics in the treatment of human periodontal disease. J Periodonol 1981; 52: 545-558.

195. Golomb G, Friedman M, Soskolne A, Stabholz A, Sela MN. Sustained release device containing metronidazole for periodontal use. J Dent Res. 1984; 63: 1149-1153.

196. Needleman IG, Martin GP, Smales FC. Characterization of bioadhesive for periodontal and oral mucosal drug delivery. J Clin Periodontol. 1998; 25: 74-82.

197. Send S, Kremer MJ, Kas S, Wertz PW, Hincal AA, Squier CA. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 2000; 21: 2067-2071.

198. Send S, Ikind G, Kas S, Yousefi-Rad A, Sargon MF, H?ncal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int JPharm. 2000; 193: 197-203.

199. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophihc drug. Int J Pharm. 2003; 252:1-9.

200. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm. 2002; 5:7-21.

201. Bernkop-Schnurch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm. 2000; 20:1-13.

202. Miyazaki S, Yamaguchi H, Takada M, Hou WM, Takeichi Y, Yasubuchi H. Preliminary study on film dosage form prepared from chitosan for oral drug delivery. Acta Pharm Nord. 1990; 2:401-406.

203. Ganguly S, Dash AK. A novel in situ gel for sustained drug delivery and targeting. Int J Pharm. 2004; 19:83-92.

204. Aksungur P, Sungur A, Unal S, Skit AB, Squier CA, End S . Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Cont Rel. 2004; 98:269-279.

179

205. Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol. 2000; 5:77-85.

206. Chandy T, Sharma CP. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials. 1992; 13:949-952.

207. Ramdas M, Dileep KJ, Anitha Y, Paul W, Sharma CP. Alginate encapsulated bioadhesive chitosan microspheres for intestinal drug delivery J Biomater Appl. 1999; 13:290-206

208. Hari PR, Chandy T, Sharma CP. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J Microencap. 1996; 13:319-329

209. Aiedeh K, Taha MO. Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon-specific drug delivery systems. Arch Pharm (Weinheim). 1999; 332:103-107.

210. Sinha VR, Kumria R. Binders for colon-specific drug delivery: an in vitro evaluation. Int J Pharm. 2002; 249:23-31.

211. Tozaki H, et al. Chitosan capsules for colon-specific delivery. J Cont Rel. 2002; 82:51-61

212. Tozaki H. Chitosan capsules for colon-specific delivery: improvement of insulin absorption from the rat colon. J Pharm Sci. 1997; 86:1016-1021.

213. Zhang H, Alsarra lA, Neau SH. An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharm. 2002; 239:197-205.

214. Kast CE. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Cont Rel. 2002; 81:354-374.

215. El-Kamel A, Sokar M, Naggar V, Gamal SA. Chitosan and sodium alginate-based bioadhesive tablets. AAPS Pharm Sci. 2002; 4(4):E44.

216. Gavini E, Sanna V, JuUano C, Bonferoni MC, Giunchedi P. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug acriflavine. AAPS Pharm Sci Tech. 2002; 3(3):E20.

217. Thacharodi D, Rao KP. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride. Biomaterials. 1995; 16:145-148.

218. Yan X, Khor E, Lim LY. PEC films prepared from chitosan-alginate coacervates. Chem Pharm Bull. 2000; 48:941-946.

180

219. Kofuji K, Akamine H, Qian CJ, Watanabe K, Togan Y, Nishimura M, Sugiyama I, Murata Y, Kawashima S. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation. Int J Pharm. 2004; 19:65-78.

220. Thacharodi D, Rao KP. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride. Biomaterials. 1995; 16:145-148. *

221. Thein-Han WW, Stevens WF. Transdermal delivery controlled by a chitosan membrane. Drug Dev Ind Pharm. 2004; 30:397-404.

222. Ilium L, Jabbal-Gill I, HinchcUffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Del Rev. 2001; 23:81-96

223.Jaraeela SR, Misra A, Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed. 1994; 6:621-632.

224. Peppas NA, Merrill EW. Differential scanning calorimetry of crystallized PVA hydrogels J AppI Poiym Sci. 1976; 20:1457-1465

225. Peppas NA, Mongia NK. Ultrapure poly(vinyl alcohol) hydrogels with mucoadhesive drug delivery characteristics. Eur J Pharm Biopharm. 1997; 43:51-58

226. Peppas NA, Langer R New challenges in biomaterials. Science. 1994; 263:1715-1720.

227. Peppas NA. Physiologically responsive gels. J Bioact Compat Polym. 1991; 6:241-246

228. Wichterle 0, Lim D. Hydrophilic gels for biological use. Nature. 1960; 185:117-118.

229. Peppas NA, Sahlin JJ. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials. 1996; 17:1553-1561.

230. Stolnik S, Ilium L, Davis SS. Long circulating microparticulate drug carriers, Adv Drug Deliv Rev. 1995; 16:195-214.

231. Peppas NA, Colombo P. Analysis of drug release behavior from swellable polymer carriers using the dimensionality index. J Cont Rel. 1997; 45:35-40.

232. Yoshi E. Cytotoxic effects of acrylates and methacrylates: relationships of monomer structures and cytotoxicity. J Biomed Mater Res. 1997; 37:517-524.

181

233. Stringer JL, Peppas NA. Diffusion of small molecular weight drugs in radiation-crosslinked poly(ethylene oxide) hydrogels. J Cont Rel. 1996; 42:195-202.

234. Byrne ME, Park K, Peppas NA. Molecular imprinting within hydrogels. Adv Drug Del Rev. 2002; 54(1):149-161

235. Scranton AB, Rangarajan B, Klier J. Biomedical applications of polyelectrolytes. Adv Polym Sci. 1995; 120:1-54.

236. Skouri R, Schoesseler F, Munch JP, Candau SJ. Swelling and elastic properties of polyelectrolytegels. Macromolecules. 1995; 28:197-210.

237. Khare AR, Peppas NA. Swelling/deswelling of anionic copolymer gels. Biomaterials. 1995; 16:559-567.

238. Knuth K, Amiji M, RobinsonJR. Hydrogel delivery systems for vaginal and oral applications. Adv Drug Del Rev. 1993; 11:137-167.

239. Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Del Rev. 1993; 11:179-191

240. Park H Park K. Biocompatibility issues of implantable drug delivery systems. Pharm Res. 1996; 13:1770-1776

241. Kitano M. Mitani Y, Takayama K, Nagai T. Buccal absorption of golden hamster cheek in vitro and in vivo of 17b-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm. 1998; 174:19-28.

242. Patel VR, Amiji MM. Preparation and characterization of freezedried chitosan±poly(ethylene oxide) hydrogels for site-speci®c antibiotic delivery in the stomach. Pharm Res. 1996; 13:588-593.

243. Akiyama Y, Lueuen HL, de Boer AG, Verhoef JC, Junginger HE. Novel peroral dosage forms with protease inhibitory activities. II. Design of fast dissolving poly(acrylate) and controlled drugreleasing capsule formulations with trypsin inhibiting properties. Int J Pharm. 1996; 138:13-23.

244. Sun YM, Huang JJ, Lin FC, Lai JY. Composite poly(2-hydroxyethyl methacrylate) membranes as rate-controlling barriers for transdermal appUcations. Biomaterials. 1997; 18:527-533.

245. Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999; 179:1-19.

246. Fang JY, Huang YB, Lin HH, Tsai YH. Transdermal iontophoresis of sodium nonivamide acetate. IV. Effect of polymer formulations. Int J Pharm. 1998; 173:127-140.

182

247. Conaghey OM, Corish J, Corrigan 01. lontophoretically assisted in vitro membrane transport of nicotine from a hydrogel containing ion exchange resins Int J Pharm. 1998; 170:225-237.

248. Zhang I, Shung KK, Edwards DA. Hydrogels with enhanced mass transfer for transdermal drug delivery. J Pharm Sci. 1996; 85:1312-1316

249. Guy RH, Hadgraft J. Selection of drug candidates for transdermal drug delivery, Transdermal Drug Delivery. New York: Marcel Dekker; 1989. p. 59-83.

250. Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Adv Drug Del Rev. 2004; 56:557-558.

251. Thomas BJ, Finnin BC. The transdermal revolution. Drug Discovery Today. 2004; 9:697-703.

252. Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Tech Today. 2000; 3:318-326.

253. Schiller PC, Schmidt. Transdermal therapeutic systems: drugs for adhesion. Pharm Zeit. 2002; 147:18-26.

254. Claudia V, Barbara GA. The use of polymers for dermal and transdermal delivery Eur J Pharm Biopharm. 2004; 58:279-289.

255. Krishnaiah YSR, Satyanarayana V, Bhaskar P. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane moderated transdermal therapeutic systems in human volunteers. Int J Pharm. 2002; 247: 91-102

256. Tipre DN, Vavia PR. Acrylate-based pressure sensitive adhesive in fabrication of transdermal therapeutic system. Polym Adv Technol. 2003; 14:502-507.

257. Venkatraman S, Gale R. Skin adhesives and skin adhesion 1. Transdermal drug delivery systems. Biomaterials. 1998; 19:1119-1136.

258. Minghetti Y, Cilurzo F, Tosi L, Casiraghi A, Montanari L. Design of a new water-soluble pressure-sensitive adhesive for patch preparation, AAPS Pharm Sci Tech. 2003; 4(1):E8.

259. Maeda H, Brandon M, Sano A. Design of controlled-release formulation for ivermectin using silicone. Int J Pharm. 2003; 261:9-19.

260. Kusum DV, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm. 2003; 29:495-503.

261. Verma PR, Iyer SS. Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2000; 26:471-476.

183

262. Guyot M, Fawaz F. Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm. 2000; 204:171-182.

263. Shin SC, Yoon MK. AppUcation of IPX polymer membranes for the controlled release of triprolidine. Int J Pharm. 2002; 232:131-137.

264. Shin SC, Lee HJ. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix. Eur J Pharm Biopharm. 2002; 54:325-328.

265. Valenta C, Walzer A, Clausen AE, Bernkop Schnuerch A. Thiolated polymers: development and evaluation of transdermal delivery systems for progesterone. Pharm Res. 2001; 18:211-216.

266. Wagner 0. Development of a new silicon-based transdermal system. I. Study of silicone elastomers and effect of liquid ingredients. Drug Dev Ind Pharm. 1998; 24:243-252

267. Hanfu. Wang, Wenjun Li, Yuhua Lu, Zhillang Wang. Studies on chitosan and Poly(acrylic acid) interpolymer complex. L Preparation, structure, pH-sensitivity, and salt sensitiviey of complex forming poly(acrylic acid): chitosan semi-interpenetrating polymer network. J AppI Poly Sci. 1997; 65:1445-1450

268. Yong Hu, Xiqun Jiang, Yin Ding, Hzixiong Ge, Yuyan Yuan, Changzheng Yang. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials. 2002; 23:3193-3201.

184